's Information
William A. Gray, MD
| Country | USA |
| Specialty | Interventional Cardiologist |
- The Series of FAME Studies: A Paradigm Shift in Our Thinking About Interventional Cardiology
- Evidence of DCB Treatment for Infrapopliteal Disease
- Leave Nothing and Suppress Restenosis: Drug-Coated Balloon
- Drug Eluting Stents and Bioresorable Scaffolds - What\'s the Latest News?
- New Design in Stent: Micromesh Technology Compared with Closed or Opened Cell Design
- Optimizing Outcomes with Tibial Atherectomy - What Experience and Data Have Taught Us
- Clinical Results and Ongoing Studies of New Drug Eluting Stent for SFA
- Invited Case Presentation & Focus Review: Between a Rock and No Place
- INSTEAD XL: Routine vs. Selective TEVAR
- How Shall We Change Our Practice on the Results of CREST/ICSS/ACT1?
- When Outcomes Matter, Design Matter
- Proximal Protection vs. Distal Protection in CAS
- ACTIVE Study: Co-Cr Balloon Expandable Stent : What Advantages over Standard Self-expandable Stent ?
- Drug-coated Balloon Technologies II: Clinical Outcomes and Recommended Applications
- Practical Aspects in FFR; When, Why and How to Use?
- From Puncture to Stent: Step by Step Technical Point Lessons from EVAR
- Evolving and Challenging Endovascular Techniques for SFA CTO
- Wrap Up Endovascular Outcomes of BTK Lesions and Future Directions
- Why CAS?
- Insights from EVEREST II: Clinical Utility of Transcatheter Edge-to-Edge Mitral Valve Repair
- Endovascular Abdominal Repair: Current Treatment and Future We Can Expect
- Endovascular Strategy for Aortoiliac Occlusive Disease: Patients Selection and Best Approach
- Achieving Optimal Clinical Results After Carotid Stenting: The PROTECT Study and Beyond...
- A Data-Driven Therapeutic Algorithm for Choosing Among Currently Available Tools for SFA Intervention
- When Is Revascularization Considered in Renal Artery Stenosis?
- Endovascular Repair of TAA & AAA
- Carotid Stenting
- Lower Extremity Revascularization: a Data-Driven Approach to SFA Disease
